Guo Xi-Ru, Liu Jue, Wang Hai-Jun
Department of Maternal and Child Health, School of Public Health, Peking University, National Health Commission Key Laboratory of Reproductive Health, Peking University Health Science Center-Weifang Joint Research Center for Maternal and Child Health, No. 38 Xueyuan Rd, Haidian District, Beijing, 100191, China.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, No. 38 Xueyuan Rd, Haidian District, Beijing, 100191, China.
Glob Health Res Policy. 2025 Apr 2;10(1):15. doi: 10.1186/s41256-025-00414-0.
There is a continued and urgent need to address the stagnation of the global maternal mortality ratio (MMR), especially for low- and middle-income countries (LMICs). We aimed to assess the impact of scaling up health intervention coverage on reducing MMR under four scenarios for 126 LMICs.
We conducted the modelling study to estimate MMR and additional maternal lives saved by intervention by 2030 for 126 LMICs using the Lives Saved Tool (LiST). We applied four scenarios to assess the impact of scaling up health intervention coverage with no scale-up (no change), a modest scale-up (increased by 2% per year), a substantial scale-up (increased by 5% per year), and universal coverage (coverage reached 95% by 2030). In sensitivity analysis, with the current trend, we assumed that coverage of each intervention remained unchanged from 2024, with MMR changing according to the annual percentage change (APC) of 2015-2020.
Among the 126 LMICs, 31.7% (40/126) countries showed an increase in MMR, and 38.1% (48/126) stalled on the reduction of MMR from 2015 to 2020. With a modest, substantial, or universal scale-up, the 2030 average MMR would be 172.1 (117.6-262.9), 139.8 (95.6-213.5) or 98.6 (67.8-149.7), not reaching the SDG Target 3.1. Additional maternal lives saved by scaling up the coverage of health interventions were mainly clustered in the African Region, the Southeast Asia Region, and the Eastern Mediterranean Region. Compared with other included interventions, uterotonics for postpartum hemorrhage, assisted vaginal delivery and cesarean delivery played more important roles in reducing maternal mortality.
The study findings highlighted that even under a substantial scale-up of intervention coverage or scaling up to universal coverage of interventions, it would be difficult for the 126 LMICs to achieve the SDG Target 3.1 on time. Optimizing the allocation of health resources, promoting health equality, taking more decisive national, regional and global actions are urgently needed for LMICs to reduce MMR and reach the SDG Target 3.1.
全球孕产妇死亡率(MMR)停滞不前的状况亟待持续且迫切地加以解决,尤其是在低收入和中等收入国家(LMICs)。我们旨在评估扩大卫生干预覆盖范围在四种情景下对126个低收入和中等收入国家降低孕产妇死亡率的影响。
我们开展了一项建模研究,使用挽救生命工具(LiST)估计126个低收入和中等收入国家到2030年通过干预措施挽救的孕产妇死亡人数和额外的孕产妇生命。我们应用了四种情景来评估扩大卫生干预覆盖范围的影响,即不扩大(无变化)、适度扩大(每年增加2%)、大幅扩大(每年增加5%)以及全民覆盖(到2030年覆盖率达到95%)。在敏感性分析中,按照当前趋势,我们假设从2024年起每项干预措施的覆盖率保持不变,孕产妇死亡率根据2015 - 2020年的年度百分比变化(APC)而变化。
在126个低收入和中等收入国家中,31.7%(40/126)的国家孕产妇死亡率有所上升,38.1%(48/126)的国家在2015年至2020年期间孕产妇死亡率下降停滞。在适度、大幅或全民扩大覆盖范围的情况下,2030年的平均孕产妇死亡率将分别为172.1(117.6 - 262.9)、139.8(95.6 - 213.5)或98.6(67.8 - 149.7),无法实现可持续发展目标3.1。通过扩大卫生干预措施的覆盖范围挽救的额外孕产妇生命主要集中在非洲区域、东南亚区域和东地中海区域。与其他纳入的干预措施相比,产后出血用宫缩剂、助产阴道分娩和剖宫产在降低孕产妇死亡率方面发挥了更重要的作用。
研究结果突出表明,即使在大幅扩大干预覆盖范围或扩大到干预措施全民覆盖的情况下,126个低收入和中等收入国家仍难以按时实现可持续发展目标3.1。低收入和中等收入国家迫切需要优化卫生资源分配、促进卫生公平,采取更具决定性的国家、区域和全球行动,以降低孕产妇死亡率并实现可持续发展目标3.1。